C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor

Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
10/2002
10/23/2002	EP0958251B1 Biological treatment of spent caustics
10/23/2002	EP0954560B1 Method and medium for detecting vancomycin-resistant enterococcus
10/23/2002	EP0925364B1 A lactic acid bacterial regulatable expression system
10/23/2002	EP0879826B1 Polysaccharide derivatives and hydraulic compositions
10/23/2002	CN1376205A Method for produicng exo polysaccharides
10/23/2002	CN1376201A Immunologically significant herpes simplex virus antigens
10/23/2002	CN1376199A Epoxide hydrolases from streptomyces
10/23/2002	CN1376195A Endo-beta-N-acetyl glucosaminidase gene
10/23/2002	CN1376194A Electron donor system for enzymes and its use for the biochemical conversion of substrates
10/23/2002	CN1376163A Highly purified cytokine activating factor and methods of use
10/23/2002	CN1376162A Novel techykinin peptides, precursor peptides thereof and genes encoding the same
10/23/2002	CN1375556A 表达调控序列 Expression control sequence
10/23/2002	CN1375553A Ferrous oxide theobacillus and sludge heavy-metal eliminating method therewith
10/23/2002	CN1375500A Thymic peptide fusion protein as one new interferon and its prepn. and use
10/23/2002	CN1375333A Biopreparation for treating hepatosis prepared in micro alternate bioelectric field and its prepn.
10/23/2002	CN1093176C Resveratrol synthase gene and its preparing process
10/23/2002	CN1093175C New structure L-asparaginase engineering bacterium and its fermented culture
10/23/2002	CN1093136C Polysaccharide derivatives and hydraulic compositions
10/22/2002	US6469144 Apo-2li (apo-2 ligand inhibitor, related to apoptosis) monoclonal antibodies
10/22/2002	US6469140 Molecules of the card-related protein family and uses thereof
10/22/2002	US6468790 Metastatic breast and colon cancer regulated genes
10/22/2002	US6468782 Cells are cultured or incubated under conditions sufficient to induce intracellular trehalose, suspended in stabilizing solution and dried to form a solid glass; storage stablility
10/22/2002	US6468779 Aqueous extract of legumes for growing agronomically beneficial microbes
10/22/2002	US6468777 Through enhanced control and stabilization of protein production via stress proteins and the resultant protein products
10/22/2002	US6468775 From a thermophilic eubacterium; polymerase shows magnesium ion dependent reverse transcriptase activity and 3'-5' exonuclease activity
10/22/2002	US6468773 Obtainable from an escherichia blattae
10/22/2002	US6468772 Methods of making modified polypeptides
10/22/2002	US6468767 DNA encoding a human dopamine D1 receptor and uses thereof
10/22/2002	US6468765 Sequencing of entire genome of haemophilus influenzae rd
10/22/2002	US6468762 High specificity homocysteinases
10/22/2002	US6468750 Cell regulation factor TTO 20
10/22/2002	US6468739 Process for identifying secretory genes from helicobacter pylori
10/22/2002	US6468546 Compositions and methods for therapy and diagnosis of ovarian cancer
10/22/2002	US6468542 Germination activated Ganoderma lucidum spores and method for producing the same
10/22/2002	US6468526 For therapy of vaginal and gastrointestinal infections
10/22/2002	US6468525 Probiotic formulation
10/22/2002	US6468330 Separators having blowers, pumps and cells, used for separation of particles from gases, then confining them in liquids for monitoring and analysis; centrifugal force
10/22/2002	CA2216601C Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/22/2002	CA2095335C Cell growth inhibitors
10/17/2002	WO2002082432A1 Isolated genome of xyllela fastidiosa and uses thereof
10/17/2002	WO2002082091A2 Method for identification of proteins from intracellular bacteria
10/17/2002	WO2002082041A2 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002	WO2002081754A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	WO2002081727A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
10/17/2002	WO2002081709A2 Modified hpv e6 and e7 genes and proteins useful for vaccination
10/17/2002	WO2002081703A2 Mitogenic oxygenase regulators
10/17/2002	WO2002081697A1 Fragment of l. lactis plasmid conferring antiphage activity and uses thereof
10/17/2002	WO2002081696A2 Oryza sativa nuclear cap binding protein 80
10/17/2002	WO2002081694A1 Method for the sectetion and production of protein
10/17/2002	WO2002081689A1 Regulation of human cyclic nucleotide-gated channel ocnc2 subunit
10/17/2002	WO2002081687A2 Yeast genes that affect viral replication
10/17/2002	WO2002081682A1 Novel clock gene promoter
10/17/2002	WO2002081677A2 Improved gene expression
10/17/2002	WO2002081676A2 Non-pathogenic bacterial recipient strain of a bacterium containing mycolic acid, method for the production thereof and use of the same
10/17/2002	WO2002081672A1 Bacterial adpglucose pyrophosphatase, method for obtaining the latter and its use in the production of assay devices and in the obtention of transgenic plants and bacteria
10/17/2002	WO2002081668A2 Desaturase genes and uses thereof
10/17/2002	WO2002081665A2 Implantation serine proteinases
10/17/2002	WO2002081661A2 Immunotherapeutic combinations for the treatment of tumours that overexpress gangliosides
10/17/2002	WO2002081659A1 Bacterial strain alcaligenes denitrificans producing nitrilase
10/17/2002	WO2002081658A2 Transgenic mice containing cacnb4 calcium ion channel gene disruptions
10/17/2002	WO2002081650A2 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast
10/17/2002	WO2002081646A2 Epitope sequences
10/17/2002	WO2002081636A2 Protein modification and maintenance molecules
10/17/2002	WO2002081631A2 Uncoupled productive and catabolic host cell pathways
10/17/2002	WO2002081626A2 D-hydantoinase from ochrobactrum anthropi
10/17/2002	WO2002081523A2 Method for preparing and selecting antibodies
10/17/2002	WO2002081519A2 Ifn-thy fusion protein,dna coding therefore,its preparation and application
10/17/2002	WO2002081517A2 Novel polypeptides and nucleic acids encoded thereby
10/17/2002	WO2002081515A1 Insulin-like growth factor-binding protein
10/17/2002	WO2002081496A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
10/17/2002	WO2002081492A1 Human gene critical to fertility
10/17/2002	WO2002080846A2 Epothilone derivatives and methods for making and using the same
10/17/2002	WO2002080681A1 Chimeric cell-targeting pathogenic organism and method of therapeutic use
10/17/2002	WO2002063036A3 Vector system used in screening active substances
10/17/2002	WO2002038607A3 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor
10/17/2002	WO2002029061A3 G-protein coupled receptors
10/17/2002	WO2002012463A3 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
10/17/2002	WO2001098354A3 Human receptors
10/17/2002	WO2001098323A3 G-protein coupled receptors
10/17/2002	WO2001090151A3 Human receptor proteins; related reagents and methods
10/17/2002	WO2001075077A3 Isolation and expression of a gene for a nitrilase from acidovorax facilis 72w
10/17/2002	WO2001055444A9 Method for the evaluation of implantable materials
10/17/2002	WO2001054510A9 Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors
10/17/2002	WO2001042423A9 Compositions and methods for detecting stress-inducible proteins
10/17/2002	WO2001040497A3 Method for obtaining nucleic acids from an environment sample
10/17/2002	US20020152503 Herbicide resistant dinitrogen fixing bacteria and method of use
10/17/2002	US20020152498 Mutant plant
10/17/2002	US20020152496 Coleopteran toxin proteins of bacillus thuringiensis
10/17/2002	US20020152485 Novel low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis
10/17/2002	US20020152481 Genetic engineering; qualitative analysis
10/17/2002	US20020151698 For diagnosis, prevention, and treatment of cancer, and neurological and immune disorders
10/17/2002	US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002	US20020151694 Release of intracellular material
10/17/2002	US20020151682 Biological products
10/17/2002	US20020151680 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins
10/17/2002	US20020151679 Peptide for use in the treatment of infections, viral and cancer diseases
10/17/2002	US20020151498 Medicaments that modify activity of Lipolysis Stimulated Receptor and that can be used to influence partitioning of dietary lipids between liver and peripheral tissues, including adipose tissue
10/17/2002	US20020151494 Novel amino acid sequences for human semaphorin-like polypeptides
10/17/2002	US20020151488 G-CSF analog compositions and methods
10/17/2002	US20020151484 SID nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof

1 ... 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 1004 1005 1006 1007 ... 1489